NYSE · Healthcare
AGILENT TECHNOLOGIES, INC. (A)
As-reported financials and recent SEC filings for AGILENT TECHNOLOGIES, INC., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$6.95B
Net income
$1.30B
Net margin
18.8%
Diluted EPS
$4.57
ROE
-576.5%
P/E (TTM)
26.0×
Market cap
$36.67B
Debt / equity
-13.5×
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2022 |
|---|---|---|---|---|---|
| Revenue | $6.95B | $6.51B | $6.83B | $6.85B | $6.32B |
| Gross profit | $3.64B | $3.54B | $3.46B | $3.72B | $3.41B |
| Operating income | $1.48B | $1.49B | $1.35B | $1.62B | $1.35B |
| Net income | $1.30B | $1.29B | $1.24B | $1.25B | $1.21B |
| Diluted EPS | $4.57 | $4.43 | $4.19 | $4.18 | $3.94 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
32026-06-05
View on EDGAR →42026-06-05
View on EDGAR →42026-06-02
View on EDGAR →10-Q2026-06-01
View on EDGAR →1442026-05-29
View on EDGAR →SD2026-05-29
View on EDGAR →8-K2026-05-27
View on EDGAR →42026-05-21
View on EDGAR →Go deeper on A
Search AGILENT TECHNOLOGIES, INC.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeData sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.